Allergy & Immunology


Clinical Interests
  • Drug hypersensitivity
  • Asthma
  • Immunodeficiency
  • Rhinosinusitis
  • Cough
  • Anaphylaxis
  • Angioedema
  • Eosinophilic disorders
  • Food sensitivity
  • Dermatitis
  • Urticaria
  • Immunology
  • Nasal polyps
Medical Education
  • MD, Northwestern University Medical School
  • Residency, Case Western Reserve University Hospital
Board Certifications
  • Allergy & Immunology
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Connecticut
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - New York
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Adult and Pediatric

Edit Profile



1995 Bachelor of Science, Biomedical Engineering, Northwestern University, Evanston, IL

1999 Medical Degree, Northwestern University Medical School, Chicago, IL

Postdoctural Training:

2002 Internal Medicine, University Hospitals of Cleveland/Case Western University, Cleveland, OH

2005 Allergy/Immunology Fellowship, Massachusetts General Hospital, Boston, MA

Edit Profile

News & Events

  • Clinical trial supports use of novel preventive therapy for dangerous swelling disorder

    A clinical trial for a new drug to prevent attacks of hereditary angioedema – a rare disorder characterized by recurrent swelling of tissues in the face, hands, gastrointestinal tract and airway – has had promising results.

  • Are you really allergic?

    One morning in late March, 26-year-old Claire Branman learned that sometimes mothers don’t always know best. This realization came after she visited the allergy testing room on the second floor of Cox – an area of the MGH where patients can walk in with a medical question and walk out about three hours later with a definitive answer.

  • New drug shown safe, effective in treating hereditary angioedema

    Clinical trials from two international research teams have shown that icatibant, a new drug that blocks the action of an inflammatory protein known as bradykinin, is safe and effective in treating acute attacks of hereditary angioedema, a potentially life-threatening condition.


Allergy Associates
55 Fruit Street
Cox Building
Boston, MA 02114-2696
Phone: 617-726-3850
Fax: 617-724-0239

Edit Profile